Testing effectiveness (Phase 2)Study completedNCT02630693
What this trial is testing
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Who this might be right for
Breast Cancer
Canadian Cancer Trials Group 180